Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AcroMetrix
AcroMetrix Announces Launch of First Liquid MRSA Positive Control
April 13th, 2008
AcroMetrix, a leading provider of quality control products and services for clinical diagnostic laboratories, announced the launch of the first standardized External Quality Control for Methicillin Resistant Staphylococcus aureas (MRSA) molecular testing. The OptiQual MRSA Positive Control may be used to independently monitor all phases of MRSA DNA testing to ensure consistent and accurate results. A study published October 2007 in the Journal of the American Medical Association estimated that MRSA infections resulted in the death of 18,650 out of 94,360 infected patients in the United States in 2005 -- death rate higher than that of HIV/AIDS in the same year. Since...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
